Knowledge (XXG)

Emtricitabine/rilpivirine/tenofovir

Source 📝

1973: 1961: 484:(excess lactic acid in blood) is a rare and potentially fatal side effect. It is characterized by the following symptoms: deep and rapid breathing, tiredness or weakness, nausea, vomiting, abnormal muscle pain, dizziness or drowsiness 1358: 542:
Use of emtricitabine/rilpivirine/tenofovir with the following medicines is contraindicated, as they lead to reduced blood levels of rilpivirine and in turn reduce the effectiveness of emtricitabine/rilpivirine/tenofovir:
820:
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services . Available from:
720: 263: 1542: 1547: 1493: 965: 1932: 218: 1129: 167: 1993: 1499: 426:
medications (where the virus has not developed resistance to these anti-HIV medications) and who have no more than 100,000 copies per mL of HIV-1 RNA in their blood (“
2008: 728: 1557: 1477: 1562: 81: 1510: 911: 116: 1532: 1516: 1527: 825: 1537: 1804: 1448: 506:(HBV) infection. Patients also diagnosed with HBV who stop taking Emtricitabine/rilpivirine/tenofovir may suddenly exacerbate their hepatitis. 1903: 1794: 1552: 750: 1567: 702: 1123: 904: 1577: 1461: 647: 621: 1587: 1572: 1352: 1332: 1250: 1235: 1223: 248: 148: 94: 69: 1467: 411:
in November 2011, for patients who have not previously been treated for HIV. It is available as a once-a-day single tablet.
1951: 889: 776: 897: 706: 404: 1920: 648:"Complera Access - emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate tablet, film coated" 724: 408: 1998: 1744: 1654: 1522: 1483: 822: 1908: 1504: 204: 622:"Complera- emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate tablet, film coated" 1582: 380: 126: 2003: 1779: 1592: 1472: 1342: 941: 39: 1488: 1337: 1095: 601: 396: 88: 48: 1597: 1456: 1328: 1246: 1045: 924: 495:(fatty liver). Presentation typically includes: skin or the white part of the eyes turning yellow ( 303: 499:), dark “tea-colored” urine, light-colored bowel movements, loss of appetite, nausea, stomach pain 178: 1885: 1880: 1739: 1402: 875: 503: 276: 106: 760: 676: 312: 1764: 865: 855: 422:
Emtricitabine/rilpivirine/tenofovir is indicated for treatment of HIV-1 in adults naïve to
1965: 1840: 1799: 959: 829: 808:
Eviplera . County Cork, Ireland: Gilead Sciences Limited.; 2013. Accessed 28 October 2014.
780: 481: 392: 1977: 1914: 1690: 1672: 1635: 920: 870: 843: 510: 384: 1987: 1680: 1430: 1265: 1151: 755: 703:"Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination" 595: 555: 551: 547: 519: 140: 60: 30:
This article is about the combination medication emtricitabine/rilpivirine/tenofovir
1734: 1724: 1305: 1295: 1113: 1070: 1065: 1060: 1022: 1002: 932: 585: 581: 577: 488: 231: 226: 773: 799:
Complera . Foster City, CA: Gilead Sciences, Inc.; 2014. Accessed 28 October 2014
1860: 1835: 1774: 1759: 1754: 1418: 1385: 1300: 1280: 1075: 1055: 1034: 981: 949: 589: 568: 134: 76: 1865: 1845: 1830: 1825: 1789: 1784: 1698: 1643: 1613: 1425: 1413: 1408: 1380: 1320: 1310: 1285: 1270: 1260: 1209: 1204: 1192: 1176: 1166: 1146: 1108: 1018: 1006: 998: 573: 564: 427: 323: 65: 1875: 1855: 1850: 1820: 1749: 1729: 1662: 1618: 1375: 1290: 1275: 1198: 1171: 1161: 1156: 1103: 1080: 993: 559: 492: 414:
In the European Union it is marketed as Eviplera and in the US as Complera.
120: 879: 823:
http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
1870: 1255: 496: 388: 211: 162: 17: 1938: 1769: 1315: 1085: 860: 400: 1972: 1719: 1714: 34:. For the combination medication emtricitabine/rilpivirine/tenofovir 348: 1029: 423: 988: 976: 339: 282: 893: 270: 157: 1013: 928: 168:
Emtricitabine, rilpivirine hydrochloride, tenofovir disoproxil
721:"Eviplera; summary of the European public assessment report" 1543:
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
774:
Complera/Eviplera (Rilpivirine + emtricitabine + tenofovir)
528:
Immune system changes (e.g. Immune Reconstitution Syndrome)
257: 189: 1548:
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil
844:"Polypharmacy in the HIV-infected older adult population" 1494:
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide
362: 1949: 1813: 1707: 1689: 1671: 1653: 1634: 1627: 1606: 1447: 1394: 1368: 1351: 1234: 1222: 1185: 1139: 1122: 1094: 1044: 958: 940: 338: 322: 302: 297: 247: 242: 217: 203: 177: 147: 133: 115: 105: 100: 87: 75: 59: 54: 1500:Dolutegravir/emtricitabine/tenofovir alafenamide 1558:Emtricitabine/rilpivirine/tenofovir alafenamide 1478:Bictegravir/emtricitabine/tenofovir alafenamide 751:"FDA approves Gilead-J&J HIV pill Complera" 671: 669: 311: 1563:Emtricitabine/rilpivirine/tenofovir disoproxil 1049:(Integrase strand transfer inhibitors (INSTI)) 82:Non-nucleoside reverse transcriptase inhibitor 1511:Dolutegravir/lamivudine/tenofovir alafenamide 905: 515:Onset of depressive disorders or mood changes 8: 1533:Efavirenz/emtricitabine/tenofovir disoproxil 1517:Dolutegravir/lamivudine/tenofovir disoproxil 509:New or worsening kidney problems, including 166: 47: 290:In general: ℞ (Prescription only) 1631: 1528:Doravirine/lamivudine/tenofovir disoproxil 1365: 1231: 1136: 912: 898: 890: 795: 793: 791: 789: 1538:Efavirenz/lamivudine/tenofovir disoproxil 869: 859: 40:Tenofovir alafenamide § combinations 2009:Drugs developed by Johnson & Johnson 1805:Zinc finger protein transcription factor 1994:Fixed dose combination (antiretroviral) 1956: 613: 525:Increases or redistribution of body fat 139: 46: 842:Gleason LJ, Luque AE, Shah K (2013). 816: 814: 125: 7: 403:division and was approved by the US 230: 1553:Emtricitabine/tenofovir alafenamide 373:Emtricitabine/rilpivirine/tenofovir 347: 49:Emtricitabine/rilpivirine/tenofovir 1568:Emtricitabine/tenofovir disoproxil 25: 407:(FDA) in August 2011, and by the 1971: 1959: 1941:. Formerly or rarely used agent. 1578:Lamivudine/nevirapine/zidovudine 1462:Abacavir/dolutegravir/lamivudine 759:. 10 August 2011. Archived from 487:Serious liver problems, such as 1745:Epigallocatechin gallate (EGCG) 1588:Lamivudine/tenofovir disoproxil 1573:Lamivudine/nevirapine/stavudine 848:Clinical Interventions in Aging 727:. November 2011. Archived from 391:. The drug was co-developed by 95:reverse-transcriptase inhibitor 70:reverse-transcriptase inhibitor 1468:Abacavir/lamivudine/zidovudine 1: 522:(breakdown and death of bone) 707:Food and Drug Administration 405:Food and Drug Administration 375:, sold under the brand name 1343:Tenofovir alafenamide (TAF) 832:. Accessed 29 October 2014. 387:drugs for the treatment of 127:Multum Consumer Information 2025: 1338:Tenofovir disoproxil (TDF) 29: 1898: 1359:Discovery and development 1130:Discovery and development 966:Discovery and development 725:European Medicines Agency 681:European Medicines Agency 598:(more than a single dose) 409:European Medicines Agency 358: 1655:Transcription inhibitors 1607:Pharmacokinetic boosters 1523:Dolutegravir/rilpivirine 1484:Cabotegravir/rilpivirine 1124:Protease Inhibitors (PI) 518:Changes in bone such as 27:Combination drug for HIV 1939:initial regimen options 1505:Dolutegravir/lamivudine 982:Enfuvirtide (ENF, T-20) 960:Entry/fusion inhibitors 828:1 November 2016 at the 1780:Portmanteau inhibitors 1673:Translation inhibitors 1583:Lamivudine/raltegravir 1353:Non-nucleoside (NNRTI) 1311:Islatravir (EFdA, ISL) 709:(FDA). 10 August 2011. 381:fixed-dose combination 1795:Synergistic enhancers 1593:Lamivudine/zidovudine 1473:Atazanavir/cobicistat 1449:Combined formulations 1286:Zidovudine (AZT, ZDV) 1224:Reverse-transcriptase 1096:Maturation inhibitors 779:9 August 2017 at the 763:on 10 September 2011. 491:(enlarged liver) and 397:Johnson & Johnson 1636:Uncoating inhibitors 1489:Darunavir/cobicistat 1329:Nucleotide analogues 1247:Nucleoside analogues 1046:Integrase inhibitors 925:antiretroviral drugs 89:Tenofovir disoproxil 1628:Experimental agents 1598:Lopinavir/ritonavir 1457:Abacavir/lamivudine 1431:Elsulfavirine (ESV) 1266:Emtricitabine (FTC) 1152:Fosamprenavir (FPV) 379:among others, is a 266:(Prescription only) 51: 1925:Never to phase III 1071:Elvitegravir (EVG) 1066:Dolutegravir (DTG) 1061:Cabotegravir (CAB) 861:10.2147/CIA.S37738 683:. 28 November 2011 654:. 20 February 2024 471:Decreased appetite 111:Complera, Eviplera 93:Nucleotide analog 1947: 1946: 1894: 1893: 1740:Diarylpyrimidines 1443: 1442: 1439: 1438: 1419:Rilpivirine (RPV) 1403:diarylpyrimidines 1386:Delavirdine (DLV) 1281:Zalcitabine (ddC) 1238:nucleotide (NRTI) 1218: 1217: 1076:Raltegravir (RAL) 1056:Bictegravir (BIC) 1035:Fostemsavir (FTR) 950:Lenacapavir (LEN) 942:Capsid inhibitors 783:, aidsinfonet.org 538:Contraindications 370: 369: 286: 274: 261: 193: 160: 16:(Redirected from 2016: 1976: 1975: 1964: 1963: 1962: 1955: 1765:Hydroxycarbamide 1632: 1426:Doravirine (DOR) 1414:Etravirine (ETR) 1409:Dapivirine (DPV) 1381:Nevirapine (NVP) 1366: 1271:Lamivudine (3TC) 1261:Didanosine (ddI) 1232: 1205:Tipranavir (TPV) 1193:Atazanavir (ATV) 1177:Saquinavir (SQV) 1167:Nelfinavir (NFV) 1147:Amprenavir (APV) 1137: 1019:Ibalizumab (IBA) 914: 907: 900: 891: 884: 883: 873: 863: 839: 833: 818: 809: 806: 800: 797: 784: 771: 765: 764: 747: 741: 740: 738: 736: 717: 711: 710: 699: 693: 692: 690: 688: 673: 664: 663: 661: 659: 644: 638: 637: 635: 633: 618: 366: 365: 351: 315: 284: 281: 272: 269: 259: 256: 234: 191: 188: 170: 159: 156: 143: 129: 52: 50: 21: 2024: 2023: 2019: 2018: 2017: 2015: 2014: 2013: 1999:Gilead Sciences 1984: 1983: 1982: 1970: 1960: 1958: 1950: 1948: 1943: 1942: 1930: 1915:Clinical trials 1890: 1841:Dexelvucitabine 1809: 1800:Tre recombinase 1703: 1685: 1667: 1663:Tat antagonists 1649: 1623: 1602: 1435: 1390: 1376:Efavirenz (EFV) 1355: 1347: 1276:Stavudine (d4T) 1237: 1225: 1214: 1199:Darunavir (DRV) 1181: 1172:Ritonavir (RTV) 1162:Lopinavir (LPV) 1157:Indinavir (IDV) 1126: 1118: 1090: 1048: 1040: 994:Maraviroc (MVC) 962: 954: 936: 921:Antiviral drugs 918: 888: 887: 841: 840: 836: 830:Wayback Machine 819: 812: 807: 803: 798: 787: 781:Wayback Machine 772: 768: 749: 748: 744: 734: 732: 719: 718: 714: 701: 700: 696: 686: 684: 677:"Eviplera EPAR" 675: 674: 667: 657: 655: 646: 645: 641: 631: 629: 628:. 26 March 2021 620: 619: 615: 610: 535: 482:Lactic acidosis 456:Abnormal dreams 436: 420: 393:Gilead Sciences 361: 359: 354: 334: 318: 293: 238: 206: 199: 180: 173: 43: 28: 23: 22: 15: 12: 11: 5: 2022: 2020: 2012: 2011: 2006: 2001: 1996: 1986: 1985: 1981: 1980: 1968: 1945: 1944: 1929: 1928: 1927: 1926: 1923: 1912: 1906: 1900: 1899: 1896: 1895: 1892: 1891: 1889: 1888: 1883: 1878: 1873: 1868: 1863: 1858: 1853: 1848: 1843: 1838: 1833: 1828: 1823: 1817: 1815: 1811: 1810: 1808: 1807: 1802: 1797: 1792: 1787: 1782: 1777: 1772: 1767: 1762: 1757: 1752: 1747: 1742: 1737: 1732: 1727: 1722: 1717: 1711: 1709: 1705: 1704: 1702: 1701: 1695: 1693: 1687: 1686: 1684: 1683: 1677: 1675: 1669: 1668: 1666: 1665: 1659: 1657: 1651: 1650: 1648: 1647: 1640: 1638: 1629: 1625: 1624: 1622: 1621: 1616: 1614:Cobicistat (c) 1610: 1608: 1604: 1603: 1601: 1600: 1595: 1590: 1585: 1580: 1575: 1570: 1565: 1560: 1555: 1550: 1545: 1540: 1535: 1530: 1525: 1520: 1514: 1508: 1502: 1497: 1491: 1486: 1481: 1475: 1470: 1465: 1459: 1453: 1451: 1445: 1444: 1441: 1440: 1437: 1436: 1434: 1433: 1428: 1423: 1422: 1421: 1416: 1411: 1398: 1396: 1392: 1391: 1389: 1388: 1383: 1378: 1372: 1370: 1363: 1349: 1348: 1346: 1345: 1340: 1324: 1323: 1318: 1313: 1308: 1303: 1298: 1293: 1288: 1283: 1278: 1273: 1268: 1263: 1258: 1256:Abacavir (ABC) 1242: 1240: 1236:Nucleoside and 1229: 1220: 1219: 1216: 1215: 1213: 1212: 1207: 1202: 1196: 1189: 1187: 1183: 1182: 1180: 1179: 1174: 1169: 1164: 1159: 1154: 1149: 1143: 1141: 1134: 1120: 1119: 1117: 1116: 1111: 1106: 1100: 1098: 1092: 1091: 1089: 1088: 1083: 1078: 1073: 1068: 1063: 1058: 1052: 1050: 1042: 1041: 1039: 1038: 1026: 1010: 996: 985: 972: 970: 956: 955: 953: 952: 946: 944: 938: 937: 919: 917: 916: 909: 902: 894: 886: 885: 834: 810: 801: 785: 766: 742: 731:on 24 May 2013 712: 694: 665: 639: 612: 611: 609: 606: 605: 604: 602:St John's wort 599: 592: 571: 562: 534: 531: 530: 529: 526: 523: 516: 513: 511:kidney failure 507: 500: 485: 473: 472: 469: 466: 463: 460: 457: 454: 451: 448: 445: 435: 432: 419: 416: 385:antiretroviral 368: 367: 356: 355: 353: 352: 344: 342: 336: 335: 333: 332: 328: 326: 320: 319: 317: 316: 308: 306: 300: 299: 295: 294: 292: 291: 288: 279: 267: 253: 251: 245: 244: 240: 239: 237: 236: 223: 221: 215: 214: 209: 207:administration 201: 200: 198: 197: 195: 185: 183: 175: 174: 172: 171: 153: 151: 145: 144: 137: 131: 130: 123: 113: 112: 109: 103: 102: 98: 97: 91: 85: 84: 79: 73: 72: 63: 57: 56: 55:Combination of 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 2021: 2010: 2007: 2005: 2002: 2000: 1997: 1995: 1992: 1991: 1989: 1979: 1974: 1969: 1967: 1957: 1953: 1940: 1937: 1934: 1924: 1922: 1919: 1918: 1916: 1913: 1910: 1907: 1905: 1902: 1901: 1897: 1887: 1884: 1882: 1879: 1877: 1874: 1872: 1869: 1867: 1864: 1862: 1859: 1857: 1854: 1852: 1849: 1847: 1844: 1842: 1839: 1837: 1834: 1832: 1829: 1827: 1824: 1822: 1819: 1818: 1816: 1814:Failed agents 1812: 1806: 1803: 1801: 1798: 1796: 1793: 1791: 1788: 1786: 1783: 1781: 1778: 1776: 1773: 1771: 1768: 1766: 1763: 1761: 1758: 1756: 1753: 1751: 1748: 1746: 1743: 1741: 1738: 1736: 1733: 1731: 1728: 1726: 1723: 1721: 1718: 1716: 1713: 1712: 1710: 1706: 1700: 1697: 1696: 1694: 1692: 1688: 1682: 1681:Trichosanthin 1679: 1678: 1676: 1674: 1670: 1664: 1661: 1660: 1658: 1656: 1652: 1645: 1642: 1641: 1639: 1637: 1633: 1630: 1626: 1620: 1619:Ritonavir (r) 1617: 1615: 1612: 1611: 1609: 1605: 1599: 1596: 1594: 1591: 1589: 1586: 1584: 1581: 1579: 1576: 1574: 1571: 1569: 1566: 1564: 1561: 1559: 1556: 1554: 1551: 1549: 1546: 1544: 1541: 1539: 1536: 1534: 1531: 1529: 1526: 1524: 1521: 1518: 1515: 1512: 1509: 1506: 1503: 1501: 1498: 1495: 1492: 1490: 1487: 1485: 1482: 1479: 1476: 1474: 1471: 1469: 1466: 1463: 1460: 1458: 1455: 1454: 1452: 1450: 1446: 1432: 1429: 1427: 1424: 1420: 1417: 1415: 1412: 1410: 1407: 1406: 1405: 1404: 1400: 1399: 1397: 1393: 1387: 1384: 1382: 1379: 1377: 1374: 1373: 1371: 1367: 1364: 1362: 1360: 1354: 1350: 1344: 1341: 1339: 1336: 1334: 1330: 1326: 1325: 1322: 1319: 1317: 1314: 1312: 1309: 1307: 1304: 1302: 1299: 1297: 1294: 1292: 1289: 1287: 1284: 1282: 1279: 1277: 1274: 1272: 1269: 1267: 1264: 1262: 1259: 1257: 1254: 1252: 1248: 1244: 1243: 1241: 1239: 1233: 1230: 1227: 1221: 1211: 1208: 1206: 1203: 1200: 1197: 1194: 1191: 1190: 1188: 1184: 1178: 1175: 1173: 1170: 1168: 1165: 1163: 1160: 1158: 1155: 1153: 1150: 1148: 1145: 1144: 1142: 1138: 1135: 1133: 1131: 1125: 1121: 1115: 1112: 1110: 1107: 1105: 1102: 1101: 1099: 1097: 1093: 1087: 1084: 1082: 1079: 1077: 1074: 1072: 1069: 1067: 1064: 1062: 1059: 1057: 1054: 1053: 1051: 1047: 1043: 1036: 1032: 1031: 1027: 1024: 1020: 1016: 1015: 1011: 1008: 1004: 1000: 997: 995: 991: 990: 986: 983: 979: 978: 974: 973: 971: 969: 967: 961: 957: 951: 948: 947: 945: 943: 939: 934: 930: 927:used against 926: 922: 915: 910: 908: 903: 901: 896: 895: 892: 881: 877: 872: 867: 862: 857: 853: 849: 845: 838: 835: 831: 827: 824: 817: 815: 811: 805: 802: 796: 794: 792: 790: 786: 782: 778: 775: 770: 767: 762: 758: 757: 756:Business Week 752: 746: 743: 730: 726: 722: 716: 713: 708: 704: 698: 695: 682: 678: 672: 670: 666: 653: 649: 643: 640: 627: 623: 617: 614: 607: 603: 600: 597: 596:dexamethasone 593: 591: 587: 583: 579: 575: 572: 570: 566: 563: 561: 557: 556:phenobarbital 553: 552:oxcarbazepine 549: 548:carbamazepine 546: 545: 544: 540: 539: 532: 527: 524: 521: 520:osteonecrosis 517: 514: 512: 508: 505: 502:Worsening of 501: 498: 494: 490: 486: 483: 480: 479: 478: 477: 470: 467: 464: 461: 458: 455: 452: 449: 446: 443: 442: 441: 440: 433: 431: 429: 425: 417: 415: 412: 410: 406: 402: 398: 394: 390: 386: 382: 378: 374: 364: 357: 350: 346: 345: 343: 341: 337: 330: 329: 327: 325: 321: 314: 310: 309: 307: 305: 301: 296: 289: 287: Rx-only 280: 278: 268: 265: 255: 254: 252: 250: 246: 241: 233: 228: 225: 224: 222: 220: 216: 213: 210: 208: 202: 196: 187: 186: 184: 182: 176: 169: 164: 155: 154: 152: 150: 146: 142: 138: 136: 132: 128: 124: 122: 118: 114: 110: 108: 104: 101:Clinical data 99: 96: 92: 90: 86: 83: 80: 78: 74: 71: 67: 64: 62: 61:Emtricitabine 58: 53: 45: 41: 37: 33: 19: 2004:Hepatotoxins 1935: 1735:Cyanovirin-N 1725:Calanolide A 1401: 1395:2 generation 1369:1 generation 1356: 1327: 1306:Elvucitabine 1296:Apricitabine 1245: 1186:2 generation 1140:1 generation 1127: 1114:Fipravirimat 1028: 1023:Semzuvolimab 1012: 1003:Cenicriviroc 987: 975: 963: 851: 847: 837: 804: 769: 761:the original 754: 745: 733:. Retrieved 729:the original 715: 697: 685:. Retrieved 680: 656:. Retrieved 651: 642: 630:. Retrieved 625: 616: 586:pantoprazole 582:lansoprazole 578:esomeprazole 541: 537: 536: 533:Interactions 489:hepatomegaly 475: 474: 438: 437: 434:Side effects 421: 418:Medical uses 413: 376: 372: 371: 360:   313:1436864-99-1 249:Legal status 243:Legal status 149:License data 44: 35: 31: 1936:recommended 1911:from market 1861:Lersivirine 1836:Capravirine 1775:Miltefosine 1760:Griffithsin 1755:Fosdevirine 1301:Censavudine 931:(primarily 590:rabeprazole 569:rifapentine 504:hepatitis B 298:Identifiers 135:MedlinePlus 107:Trade names 77:Rilpivirine 36:alafenamide 1988:Categories 1866:Lodenosine 1846:Droxinavir 1831:Brecanavir 1826:Atevirdine 1790:Seliciclib 1785:Scytovirin 1699:Elipovimab 1644:TRIM5alpha 1321:Stampidine 1226:inhibitors 1210:TMC-310911 1109:BMS-955176 1007:Leronlimab 999:Vicriviroc 854:: 749–63. 735:29 January 608:References 574:omeprazole 565:rifampicin 428:viral load 324:ChemSpider 304:CAS Number 66:Nucleoside 32:disoproxil 1921:Phase III 1909:Withdrawn 1886:Telinavir 1881:Palinavir 1876:Mozenavir 1856:Emivirine 1851:Lasinavir 1821:Aplaviroc 1750:Foscarnet 1730:Ceragenin 1291:Amdoxovir 1104:Bevirimat 1081:BI 224436 594:systemic 560:phenytoin 493:steatosis 459:Dizziness 205:Routes of 179:Pregnancy 121:Drugs.com 1966:Medicine 1871:Loviride 880:23818773 826:Archived 777:Archived 652:DailyMed 626:DailyMed 497:jaundice 468:Weakness 462:Headache 453:Insomnia 450:Vomiting 444:Diarrhea 389:HIV/AIDS 377:Complera 363:(verify) 219:ATC code 212:By mouth 194: B3 181:category 163:DailyMed 18:Complera 1978:Viruses 1952:Portals 1770:KP-1461 1316:Racivir 1086:MK-2048 871:3693722 705:. U.S. 687:20 June 658:20 June 632:20 June 476:Serious 401:Tibotec 235:) 229: ( 227:J05AR08 165::  141:a616021 68:analog 1904:WHO-EM 1720:BIT225 1715:Abzyme 1646:(gene) 1333:NtRTIs 1228:(RTIs) 878:  868:  447:Nausea 439:Common 349:D10571 277:℞-only 275: 262: 161:  38:, see 1708:Other 1691:BNAbs 1251:NRTIs 1030:gp120 424:HIV-1 1933:DHHS 989:CCR5 977:gp41 876:PMID 737:2012 689:2024 660:2024 634:2024 465:Rash 430:”). 395:and 340:KEGG 331:none 117:AHFS 1014:CD4 933:J05 929:HIV 866:PMC 856:doi 399:'s 383:of 232:WHO 1990:: 1917:: 1021:, 1005:, 1001:, 923:: 874:. 864:. 850:. 846:. 813:^ 788:^ 753:. 723:. 679:. 668:^ 650:. 624:. 588:, 584:, 580:, 576:, 567:, 558:, 554:, 550:, 283:EU 271:US 264:S4 258:AU 190:AU 158:US 1954:: 1931:° 1519:° 1513:° 1507:° 1496:° 1480:° 1464:° 1361:) 1357:( 1335:: 1331:/ 1253:: 1249:/ 1201:° 1195:° 1132:) 1128:( 1037:) 1033:( 1025:) 1017:( 1009:) 992:( 984:) 980:( 968:) 964:( 935:) 913:e 906:t 899:v 882:. 858:: 852:8 739:. 691:. 662:. 636:. 285:: 273:: 260:: 192:: 119:/ 42:. 20:)

Index

Complera
Tenofovir alafenamide § combinations
Emtricitabine
Nucleoside
reverse-transcriptase inhibitor
Rilpivirine
Non-nucleoside reverse transcriptase inhibitor
Tenofovir disoproxil
reverse-transcriptase inhibitor
Trade names
AHFS
Drugs.com
Multum Consumer Information
MedlinePlus
a616021
License data
DailyMed
Emtricitabine, rilpivirine hydrochloride, tenofovir disoproxil
Pregnancy
category

Routes of
administration

By mouth
ATC code
J05AR08
WHO
Legal status
S4
℞-only
CAS Number
1436864-99-1
ChemSpider

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.